French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy.
D026661:Clinical Trials Data Monitoring Committees; D002986:Clinical Trials as Topic; D005060:Europe; D040181:Genetic Diseases, X-Linked / Q000235:genetics / Q000628:therapy*; D015316:Genetic Therapy / Q000009:adverse effects / Q000331:legislation & jurisprudence; D006801:Humans; D016511:Severe Combined Immunodeficiency / Q000235:genetics / Q000628:therapy*